Previous 10 | Next 10 |
DURECT Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and AHFIRM Trial Update PR Newswire - Webcast of Earnings Call Today, March 7 th at 4:30 p.m. ET - Topline data from AHFIRM trial expected in 2023 CUPERTINO, Ca...
DURECT Corporation to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 7 PR Newswire CUPERTINO, Calif. , Feb. 28, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its f...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As an investor, you can get some amazing deals in the stock market. You can even fund some great stocks under $10 to buy if you know where to look. What’s the attraction to buying a stock under $10? Well, not everyone ...
DURECT ( NASDAQ: DRRX ) shares are down 23.4% after-hours on Friday after the firm has entered into pact with a leading institutional healthcare investor and an existing institutional investor for the purchase and sale of an aggregate of 1.7M shares of common stock and, in lieu of sha...
DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants PR Newswire CUPERTINO, Calif. , Feb. 3, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epige...
DURECT Announces 1-for-10 Reverse Stock Split PR Newswire CUPERTINO, Calif. , Nov. 28, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ...
DURECT Corporation (DRRX) Q3 2022 Earnings Conference Call November 02, 2022, 04:30 PM ET Company Participants Tim Papp - Chief Financial Officer Jim Brown - Chief Executive Officer Norman Sussman - Chief Medical Officer Keith Louie - Business Development and...
Durect press release ( NASDAQ: DRRX ): Q3 GAAP EPS of -$0.01 in-line. Revenue of $11.98M (vs. $2.17M last year) misses by $1.01M . At September 30, 2022, cash and investments were $52M, compared to cash and investments of $70M at December 31, 2021. For furthe...
DURECT Corporation Reports Third Quarter 2022 Financial Results and Update of Programs PR Newswire - Webcast of Earnings Call Today, November 2 nd at 4:30 p.m. ET - AHFIRM trial timeline continues to improve CUPERTINO, Calif. ,...
DURECT Corporation to Announce Third Quarter 2022 Financial Results and Provide Business Update on November 2 PR Newswire CUPERTINO, Calif. , Oct. 26, 2022 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its third...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Ea...